H. Zwierzina

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Giuseppe Giaccone, Cornelis J. A. Punt, Rita Ruijter et al. · PubMed · 2002 · 507 citations

Medicine, Oncology, Pharmacology +17

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

Gordon C. Jayson, Jamal Zweit, Alan Jackson et al. · JNCI Journal of the National Cancer Institute · 2002 · 257 citations · Full text

Medicine, Oncology, Cancer Pharmacology +16

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin et al. · PubMed · 2002 · 204 citations

Medicine, Immunology, Oncology +17

Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells

Arno Amann, Marit Zwierzina, Gabriele Gamerith et al. · PLoS ONE · 2014 · 165 citations · Full text

Medicine, Cell Biology, Oncology +17

Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma

Judith Löffler‐Ragg, Martina Witsch‐Baumgartner, Alexandar Tzankov et al. · European Journal of Cancer · 2005 · 156 citations · Full text

Medicine, Molecular Genetics, Oncology +9